Company Profile

EpiCypher Inc
Profile last edited on: 9/20/2022      CAGE: 6XLY4      UEI: UWNWSADJYYZ3

Business Identifier: Epigenetics and chromatin biology research tools and diagnostics
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

PO Box 14453
Research Triangle Park, NC 27709
   (855) 374-2461
Location: Single
Congr. District: 04
County: Durham

Public Profile

An early player in the field of epigenetics and chromatin biology, EpiCypher was founded, in some measure, in response to the growing demand for high-quality reagents and tools to study chromatin regulation and enable epigenetics-focused drug development. Working in the arena of recombinant nucleosome manufacturing and development, using proprietary methods, the firm is consistently adding to the largest collection of highly pure modified recombinant “designer” nucleosomes (dNucs™). The firm's broad dNuc™ diversity is providing a powerful tool to decipher the histone code and accelerate drug development. The firm leverages dNuc™ technology for a wide range of applications, including: SNAP-ChIP® Spike-in Controls (for antibody profiling and quantitative ChIP), EpiDyne® substrates (for characterizing chromatin remodeling enzyme complexes and inhibitors), and dCypher™ assays (for interrogation of epigenetic protein-histone PTM binding interactions) while also offering a suite of high-quality recombinant histone binding proteins, enzymes, peptides, antibodies, and custom assay development services to complement these platforms. Continuously pushing out the technology boundaries to deliver innovative products, solutions, and services to epigenetics and chromatin biology researchers, most recently, EpiCypher has been at the leading edge of chromatin mapping technology improvements with the recent launch of the highly sensitive epigenomic mapping CUTANA™ assays for ChIC, CUT&RUN, and CUT&Tag.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  James Bone -- President and Chief Operating Officer

  Sam Tetlow -- Founder and Chief Executive Officer

  Jonathan M Burg

  Martis Cowles -- Chief Business Officer.

  Laila Elsherif

  Andrea Lynn Johnstone -- Director of Product Development

  Mark Kaderli -- Director of Sales

  Michael-Christopher Keogh -- Chief Scientific Officer

  Matt Meiners -- Director of Operations and Production.

  Zu-Wen Sun -- Chief Scientific Officer

  Bryan J Venters